Columbia Sportswear Company Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments And Risk Management (Tables)

3 Months Ended

Mar. 31, 2017

The following table presents the gross notional amount of outstanding derivative instruments (in thousands):



	March 31, 2017		December 31, 2016		March 31, 2016
Derivative instruments designated as cash flow hedges:
Currency forward contracts	$	233,500	$	206,000	$	228,500
Derivative instruments not designated as cash flow hedges:
Currency forward contracts	168,361		184,940		60,785

The following table presents the balance sheet classification and fair value of derivative instruments (in thousands):



	Balance Sheet Classification	March 31, 2017		December 31, 2016		March 31, 2016
Derivative instruments designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	$	6,347	$	9,805	$	409
Currency forward contracts	Other non-current assets	1,619		1,969		63
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	134		106		3,524
Currency forward contracts	Other long-term liabilities	—		—		922
Derivative instruments not designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	292		1,361		7
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	220		180		727

The following table presents the statement of operations effect and classification of derivative instruments (in thousands):



	Statement of Operations Classification	Three Months Ended March 31,
	Statement of Operations Classification	2017			2016
Currency Forward and Option Contracts:
Derivative instruments designated as cash flow hedges:
Loss recognized in other comprehensive income or loss	—	$	(1,438	)	$	(7,138	)
Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion	Net sales	144			161
Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion	Cost of sales	54			1,434
Gain recognized in income for amount excluded from effectiveness testing and for the ineffective portion	Net sales	3			4
Gain recognized in income for amount excluded from effectiveness testing and for the ineffective portion	Cost of sales	794			422
Derivative instruments not designated as cash flow hedges:
Loss recognized in income	Other non-operating expense	(1,688		)	(1,554		)